CSL Research Acceleration Initiative Info Session
Applications for the CSL Research Acceleration Initiative close February 20, 2025.
CSL is a leading global biotech company that develops and delivers innovative biotherapies to help people living with life-threatening medical conditions live full lives. CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations. Successful applicants will receive funding of up to $400,000 USD over 2 years.
Interested researchers are invited to:
- Attend information webinars to learn more about the initiative: Thursday, January 23 at 1pm ET or Wednesday, February 5 at 11am ET.
- Contact Pragati Sharma to express interest in applying and to obtain online application submission instructions.
- Submit a non-confidential, 300 word abstract via the CSL online application portal by February 20, 2025.
Click here for more information on the Research Acceleration Initiative.